conclusion of the procedure. At the time of drug administration, surgeons became unblinded, but did not collect outcome data. Participants remained blinded to treatment. Surgical procedures and perioperative care were standardized. The primary outcome was Visual Analog Scale (VAS) pain score 4 hours after discharge home. Secondary outcomes included narcotic consumption, time to first bowel movement, and VAS pain scores collected in the mornings and evenings until postoperative day (POD) 6. The morning VAS item assessed "current level of pain," and evening items queried "current level of pain," "most intense pain today," "average pain today with activity," and "average pain today with rest." Likert scales were used to measure satisfaction with pain control at 1 and 2 week postoperative intervals. Sample size calculation deemed 52 subjects per arm necessary to detect a mean difference of 10 mm on 100 mm VAS. To account for 10% drop out, 114 participants were needed. RESULTS: One hundred fourteen women were enrolled. After 5 exclusions, 109 were analyzed: 54 received LB, and 55 received P. Mean participant age was 52 years, and mean BMI was 30.4. Surgical and demographic characteristics were similar except a slightly higher BMI in the P arm (31.6 vs 29.2, p ¼ 0.050), and more subjects received midazolam during anesthesia induction in the LB arm (52 vs 44, p ¼ 0.015). For the primary outcome, the VAS pain score (mm) was lower in the LB group 4 hours after discharge home (3.5 vs 13, p ¼ 0.014). VAS scores were also lower for LB subjects at the following collected time points: POD 1 morning "current level of pain" (9.5 vs 27, p ¼ 0.014), POD 2 "average pain with rest" (5.5 vs 10, p ¼ 0.027), POD 3 morning "current level of pain" (6 vs 10, p ¼ 0.011), and POD 3 "average pain with rest" (4 vs 7, p ¼ 0.043). Furthermore, fewer LB participants consumed narcotic medication on POD 2 (12 vs 27, p ¼ 0.006). There was no difference in satisfaction with pain control between groups. Side effects experienced, rate of postoperative urinary retention, and time to first bowel movement were also similar between arms. Finally, no serious adverse events were noted. CONCLUSION: Liposomal bupivacaine decreased postoperative pain scores following retropubic midurethral sling placement. Participants who received liposomal bupivacaine were also less likely to use narcotics on POD 2. No differences in side effects or adverse events were observed between groups. For this common outpatient surgery, liposomal bupivacaine may be a beneficial addition for pain control.
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OBJECTIVES:
Liposomal bupivacaine is an extended-release, local subcutaneous anesthetic preparation providing up to 72 hours of pain relief. However, few studies have evaluated its use in pelvic reconstructive surgery.
MATERIALS AND METHODS:
This was a prospective, randomized, patient-blinded, placebo-controlled trial of patients undergoing robotic-assisted sacrocolpopexy with rectocele repair. Either liposomal bupivacaine or normal saline was injected subcutaneously into laparoscopic port sites and posterior repair incision at the completion of surgery. Perioperative care was standardized for both groups. Visual analog scales (VAS) were collected in the hospital at 4, 18, and 24 hours following surgery. Upon discharge, participants were asked to complete twice daily VAS questionnaires and a pain medication diary until postoperative day 3. The primary outcome was VAS for pain 18 hours after surgery. Secondary measures included nursing administered verbal pain scores, satisfaction with pain control, narcotic use (morphine equivalents), location of "the most painful" site, voiding trial results, and time to first bowel movement. Our sample size calculation revealed 32 subjects per arm were required to detect a mean difference of 20 mm on the Visual Analog Scale (VAS). To allocate for dropout, a goal of 70 was set. RESULTS: Seventy patients were enrolled; 6 were excluded: 2 converted to vaginal repairs, 2 withdrew after randomization, 1 patient had an elevated creatinine, and 1 reported a history of cocaine abuse. Sixty-four subjects were analyzed: 33 received liposomal bupivacaine (LB) and 31 received normal saline (NS). The mean age was 62 (SD 13), and mean body mass index was 27.3 (SD 6.9). There was no difference in demographics, surgical data, voiding trial results, time to first bowel movement, or satisfaction scores between the cohorts. While the median VAS score at 18 hours after surgery was lower for those who received liposomal bupivacaine (15 Only nursing verbal pain scores on postoperative day one were significantly lower in the bupivacaine group (LB: 2.0 vs NS: 3.0; P ¼ 0.049). When comparing all abdominal incisions, participants noted the umbilical site to be the most painful. However, there was no significant difference between overall abdominal incision pain and vaginal incision pain among or between groups. Most common reported side effects included nausea, itching, insomnia, and irritation at the injection sites, with no differences based on treatment allocation. CONCLUSION: In this study of robotic assisted sacrocolpopexy with rectocele repair, there was no significant difference in VAS scores or narcotic use between liposomal bupivacaine and normal saline for local analgesia. A modest benefit was noted only in nursing administered pain scores. Given potential increased expense and risk of adverse events with liposomal bupivacaine, we do not support its routine use for this surgical intervention.
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Jennifer Yeung: Nothing to disclose; Catrina C. Crisp: Nothing to disclose; Donna Mazloomdoost: Nothing to disclose; Steven D. Kleeman: Nothing to disclose; Rachel N. Pauls: Nothing to disclose. OBJECTIVES: Laparoscopic myomectomy (LM) is considered the gold standard for surgical management of uterine leiomyoma; however, when compared to abdominal myomectomy, it is associated with prolonged operative time (OT), higher cost, risk of leiomyoma recurrence and weaker uterine defect repair. The purpose of this study is to compare surgical outcomes of commonly performed Oral Presentations ajog.org myomectomy techniques with laparoscopically assisted abdominal myomectomy (LAAM), a hybrid approach combining both laparoscopic and abdominal techniques using an ultra-minilaparotomy incision and bilateral uterine artery occlusion to control blood loss. MATERIALS AND METHODS: A retrospective chart review of 1380 patients undergoing myomectomy for benign indications at a community hospital from 2011 to 2013. Myomectomies performed via abdominal, conventional laparoscopic (CLM), robotic-assisted (RAM), and LAAM approaches were included in the study. Data collected included patient & leiomyoma characteristics, and surgical outcomes such as EBL, operating time (OT), length of stay (LOS), conversions to laparotomy and complications. Nonparametric Kruskal-Wallis tests were used to compare surgical outcomes across myomectomy techniques. Post hoc comparisons between LAAM and each of the other myomectomy approaches were performed using Bonferroni-adjusted Wilcoxon rank sum test. RESULTS: Patient characteristics were equally distributed among surgical groups. Average aggregate leiomyoma weight removed via LAAM technique was 389 gm, significantly larger than leiomyomas removed via CLM and RAM at 223 gm and 269 gm respectively (p < 0.001). When controlling for leiomyoma weight, LAAM had lowest average EBL among all surgical routes, 162 ml vs 181 ml for CLM, 166 ml for RAM, and 266 ml for abdominal approach. LAAM had the shortest OT with a mean of 73.9 min (p < 0.001) vs 101.6 min for CLM, 145.6 min for RAM and 96.8 min for abdominal. LAAM also had the shortest LOS at 0.4 days compared to 0.9 days for combined laparoscopic modalities and 2.5 days for abdominal (p < 0.001). The rate of conversion to mini-lap was highest for CLM at 20.9% vs 17.3% for RAM. Rate of conversion to laparotomy was also highest for CLM at 16.6% followed by RAM at 6.4% and lowest for LAAM at 0.6% (p < 0.001). Despite removal of higher leiomyoma volume in LAAM group, no difference in overall complication rates were noted between LAAM and combined LM approaches, but a statistically significant difference was noted between LAAM (10.0%) and abdominal group (19.9%, p < 0.015). LAAM also had the lowest direct hospital costs, which were primarily driven by operating room times and LOS. A second analysis examining only cases performed by high-volume surgeons revealed similar results. CONCLUSION: LAAM approach had higher total specimen weight removed, lower average EBL, shorter operating time, and comparable or lower complication rates when compared to other myomectomy techniques. LAAM as a cost effective minimally invasive technique overcomes the inherent technical challenges associated with laparoscopic myomectomy such as the inability to palpate small leiomyoma, limitation in tissue removal and uterine defect repair by combining the best benefits of abdominal and laparoscopic myomectomies.
Rupen P. Baxi: Nothing to disclose; Louise van der Does: Nothing to disclose; Paul Mackoul: Co-owner of CIGC, surgeon, co-owner, salary; Natalya Danilyants: Co-owner of CIGC, surgeon, co-owner, salary; Leah Haworth: Nothing to disclose. OBJECTIVES: Known risks of surgical treatment for pelvic organ prolapse (POP) include intraoperative complications, unmasking stress urinary incontinence (SUI) and recurrent POP. We aimed to examine the rate and indications for reoperation after hysterectomy for POP. Specifically, we evaluated whether the type of apical support procedure affected the rate of and indications for reoperation.
MATERIALS AND METHODS:
This was an investigational review board approved retrospective study of all patients who underwent hysterectomy for POP within a large health care maintenance organization (HMO) in 2008. Surgeries were identified by procedural codes. The electronic medical record (EMR) was reviewed for demographic and clinical data, including apical procedures performed and reoperation details as available up to March 1, 2016. Data was analyzed using descriptive statistics. Inferential statistics with chi-squared tests were performed to compare reoperation rates. P-values less than 0.05 were considered statistically significant. RESULTS: Six hundred thirty hysterectomies for POP were performed in 2008 and had information available regarding performance of apical repair. Mean length of follow-up was 6.3 years (Standard Deviation ¼ 2.0 years). One hundred and nine patients (17%) underwent at least 1 subsequent related operation. Twenty-seven patients (4%) had subsequent operations with multiple indications (e.g. SUI and POP). Separate indications were addressed either in the same operation or multiple surgeries. Five hundred twelve patients (81%) had an apical repair at the time of hysterectomy for POP. Patients who had an apical repair were significantly more likely to undergo subsequent operation for SUI or another, non-POP or SUI related indication (such as voiding dysfunction or mesh exposure) compared to those who did not (Table 1) . Rates of reoperation for POP were similar regardless of performance of apical repair procedure. When type of apical support procedure was examined, there were no significant differences in the rates of reoperation by type of apical support procedure (Table 2) . CONCLUSION: In an HMO cohort with long-term follow-up, patients who had apical support procedures at time of hysterectomy for POP were significantly more likely to undergo subsequent operation for SUI. This finding is consistent with literature that demonstrates correction of apical prolapse can unmask occult SUI. The increased rate of reoperation for non-POP or SUI indications when apical prolapse repair is performed suggests additional morbidity may be associated with the apical procedure itself or its concurrent procedures. This merits further investigation.
